| Date | Company Name | Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|---|
| Nov 15, 2022 | Jnana Therapeutics | Series C | — | Biotechnology | Yes |
| Sep 12, 2022 | Nimbus Therapeutics | Series Unknown | — | Biotechnology | — |
| Jul 12, 2022 | Areteia Therapeutics | Series A | — | Biotechnology | Yes |
| Jun 30, 2022 | X4 Pharmaceuticals | Post-IPO Equity | — | Biotechnology | — |
| Dec 7, 2021 | Freenome | Series D | — | Biotechnology | — |
| Mar 19, 2021 | X4 Pharmaceuticals | Post-IPO Equity | — | Biotechnology | — |
| Aug 26, 2020 | Freenome | Series C | — | Biotechnology | Yes |
| Dec 10, 2019 | Marinus Pharmaceuticals | Post-IPO Equity | — | Biopharma | — |
| Sep 14, 2017 | Marinus Pharmaceuticals | Post-IPO Equity | — | Biopharma | Yes |
| Sep 8, 2017 | Replimune Group | Series B | — | Biotechnology | Yes |